Clinical efficacy of peripheral blood mononuclear cell secretome application in patients with repeated implantation failure
Keywords:
peripheral blood mononuclear cell secretome, chronic endometriti, infertilityAbstract
Abstract.
Background and aim: Recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL) are significant challenges in reproductive medicine, often linked to endometrial dysfunction and chronic endometritis (CE). Current treatments, including antibacterial therapies, are not always effective. This study aims to evaluate the clinical efficacy of peripheral blood mononuclear cell (PBMC) secretome in enhancing endometrial receptivity and improving pregnancy rates in patients with RIF associated with CE.
Methods: At present, the researches for alternative agents for the complex treatment of chronic endometritis are conducted. One of the promising options is the introduction of peripheral blood mononuclear cell (PBMC) secretome containing a variety of biologically active substances, including proteins, extracellular vesicles, antimicrobial peptides, nucleotides, lipids, interleukins and cytokines necessary for endometrial receptivity enhancement in patients with chronic endometritis and infertility. A total of 54 women with long-term infertility were enrolled and divided into two groups: the main group receiving PBMC secretome and a comparison group undergoing standard antibacterial therapy. The PBMC secretome was prepared from cultured PBMCs, and its biological activity was assessed
Results: In our study, the pregnancy rate in patients with long-term infertility after PBMC secretome administration was significantly higher when compared to women after antibacterial therapy
Conclusions: The application of PBMC secretome appears to enhance reproductive outcomes in women with RIF due to CE. These findings support the potential of PBMC secretome as a novel therapeutic option for improving endometrial health and warrant further investigation in larger clinical trials. (www.actabiomedica.it)
References
HogenEsch E, Hojjati R, Komorowski A, et al. Chronic endometritis: screening, treatment, and pregnancy outcomes in an academic fertility center. J Assist Reprod Genet. 2023;40(10):2463-2471. doi:10.1007/s10815-023-02902-z.
Medenica S, Abazovic D, Ljubić A, et al. The Role of Cell and Gene Therapies in the Treatment of Infertility in Patients with Thyroid Autoimmunity. Int J Endocrinol. 2022 Aug 30;2022:4842316. doi: 10.1155/2022/4842316. PMID: 36081621; PMCID: PMC9448571.
Gugerell A, Gouya-Lechner G, Hofbauer H, et al. Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II. Trials. 2021;22(1):10. Published 2021 Jan 6. doi:10.1186/s13063-020-04948-1.
Ministry of Health of the Russian Federation. Registration system for hazardous substances. GRLS. Available from: https://grls.rosminzdrav.ru/Grls_viewFS_v2.aspx?routingGuid=89391e82-9c2b-44a7-b316-8074b6838f7a
Simader E, Traxler D, Kasiri MM, et al. Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I). Sci Rep. 2017 Jul 24;7(1):6216. doi: 10.1038/s41598-017-06223-x.
Patent Office of the Russian Federation. Patent RU2145500C1. Patenton. Available from: https://patenton.ru/patent/RU2145500C1.
Kitaya K, Tada Y, Taguchi S, Funabiki M, Hayashi T, Nakamura Y. Local mononuclear cell infiltrates in infertile patients with endometrial macropolyps versus micropolyps. Hum Reprod. 2012;27(12):3474-3480. doi:10.1093/humrep/des323.
Yang R, Du X, Wang Y, Song X, Yang Y, Qiao J. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet. 2014;289(6):1363-1369. doi:10.1007/s00404-013-3131-2.
Moyer DL, Mishell DR Jr, Bell J. Reactions of human endometrium to the intrauterine device. I. Correlation of the endometrial histology with the bacterial environment of the uterus following short-term insertion of the IUD. Am J Obstet Gynecol. 1970;106(6):799-809. doi:10.1016/0002-9378(70)90470-9.
Liu Y, Chen X, Huang J, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure [published correction appears in Fertil Steril. 2019 Feb;111(2):411. doi: 10.1016/j.fertnstert.2018.12.004]. Fertil Steril. 2018;109(5):832-839. doi:10.1016/j.fertnstert.2018.01.022.
Torlakovic EE, Nielsen S, Vyberg M, Taylor CR. Getting controls under control: the time is now for immunohistochemistry. J Clin Pathol. 2015;68(11):879-882. doi:10.1136/jclinpath-2014-202705
Kasius JC, Fatemi HM, Bourgain C, et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril. 2011;96(6):1451-1456. doi:10.1016/j.fertnstert.2011.09.039
Cicinelli E, De Ziegler D, Nicoletti R, et al. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril. 2008;89(3):677-684. doi:10.1016/j.fertnstert.2007.03.074
Cicinelli E, De Ziegler D, Nicoletti R, et al. Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis. Gynecol Obstet Invest. 2009;68(2):108-115. doi:10.1159/000223819
Buzzaccarini G, Vitagliano A, Andrisani A, et al. Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review. J Assist Reprod Genet. 2020;37(12):2897-2911. doi:10.1007/s10815-020-01955-8
Tapilskaya NI, Savicheva AM, Shalepo KV, et al. Local Immune Biomarker Expression Depending on the Uterine Microbiota in Patients with Idiopathic Infertility. Int J Mol Sci. 2023;24(8):7572. Published 2023 Apr 20. doi:10.3390/ijms24087572
Cicinelli E, McQueen DB, Huepfel B, et al. Should patients be screened for chronic endometritis before assisted reproductive technology?. Fertil Steril. 2022;118(4):639-652. doi:10.1016/j.fertnstert.2022.08.846
Li Y, Yu S, Huang C, et al. Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure. Fertil Steril. 2020;113(1):187-196.e1. doi:10.1016/j.fertnstert.2019.09.001
Samodelkin EI, Mercucheva NG, Kosareva PV, Nesterova LY. Patol Fiziol Eksp Ter. 2017;61(2):98-100. [In Russ.]
Sekulovski N, Whorton AE, Shi M, MacLean JA II, Hayashi K. Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†. Biol Reprod. 2019;100(2):398-408. doi:10.1093/biolre/ioy222
Laggner M, Copic D, Nemec L, et al. Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation. EBioMedicine. 2020;55:102774. doi:10.1016/j.ebiom.2020.102774
Maleki-Hajiagha A, Razavi M, Rezaeinejad M, et al. Intrauterine administration of autologous peripheral blood mononuclear cells in patients with recurrent implantation failure: A systematic review and meta-analysis. J Reprod Immunol. 2019;131:50-56. doi:10.1016/j.jri.2019.01.001
Gharibeh N, Aghebati-Maleki L, Madani J, Pourakbari R, Yousefi M, Ahmadian Heris J. Cell-based therapy in thin endometrium and Asherman syndrome. Stem Cell Res Ther. 2022;13(1):33. Published 2022 Jan 28. doi:10.1186/s13287-021-02698-8
Sfakianoudis K, Simopoulou M, Nitsos N, et al. Successful Implantation and Live Birth Following Autologous Platelet-rich Plasma Treatment for a Patient with Recurrent Implantation Failure and Chronic Endometritis. In Vivo. 2019;33(2):515-521. doi:10.21873/invivo.11504
Agrawal GK, Jwa NS, Lebrun MH, Job D, Rakwal R. Plant secretome: unlocking secrets of the secreted proteins. Proteomics. 2010;10(4):799-827. doi:10.1002/pmic.200900514
Waters R, Alam P, Pacelli S, Chakravarti AR, Ahmed RPH, Paul A. Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue. Acta Biomater. 2018;69:95-106. doi:10.1016/j.actbio.2017.12.025
Giordano G, Gullo G, Scaglione M, et al. Transplacental permeability of heavy metals in relation to newborn sex - evidence from the neurodevelopment project. Prz Menopauzalny. 2023 Mar;22(1):30-36. doi: 10.5114/pm.2023.126437. Epub 2023 Apr 3. PMID: 37206674; PMCID: PMC10189668.
Gullo G, Scaglione M, Cucinella G, et al. Impact of assisted reproduction techniques on the neuro-psycho-motor outcome of newborns: a critical appraisal. J Obstet Gynaecol. 2022 Oct;42(7):2583-2587. doi: 10.1080/01443615.2022.2109953. Epub 2022 Aug 12. PMID: 35959847.
Gullo G, Scaglione M, Buzzaccarini G, et al. Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis of Chromosomopathies and Pediatric Monogenic Diseases: A Critical Appraisal and Medicolegal Remarks. J Pers Med. 2022 Dec 20;13(1):1. doi: 10.3390/jpm13010001. PMID: 36675662; PMCID: PMC9862851.
Gullo G, Scaglione M, Cucinella G, et al. Neonatal Outcomes and Long-Term Follow-Up of Children Born from Frozen Embryo, a Narrative Review of Latest Research Findings. Medicina (Kaunas). 2022 Sep 4;58(9):1218. doi: 10.3390/medicina58091218. PMID: 36143894; PMCID: PMC9500816
Gullo G, Perino A, Cucinella G. Open vs. closed vitrification system: which one is safer? Eur Rev Med Pharmacol Sci. 2022 Feb;26(4):1065-1067. doi: 10.26355/eurrev_202202_28092. PMID: 35253158.
Mitchell R, Mellows B, Sheard J, et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther. 2019;10(1):116. Published 2019 Apr 5. doi:10.1186/s13287-019-1213-1
Laggner M, Gugerell A, Bachmann C, et al. Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products. Stem Cell Res Ther. 2020;11(1):9. Published 2020 Jan 3. doi:10.1186/s13287-019-1524-2
A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds. ClinicalTrials.gov. Available from: https://clinicaltrials.gov/study/NCT02284360.
L PK, Kandoi S, Misra R, S V, K R, Verma RS. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev. 2019;46:1-9. doi:10.1016/j.cytogfr.2019.04.002
Soller JT, Murua-Escobar H, Willenbrock S, et al. Comparison of the human and canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians. J Hered. 2007;98(5):485-490. doi:10.1093/jhered/esm025
Bolintineanu DS, Kaznessis YN. Computational studies of protegrin antimicrobial peptides: a review. Peptides. 2011;32(1):188-201. doi:10.1016/j.peptides.2010.10.006
Kościuczuk EM, Lisowski P, Jarczak J, et al. Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep. 2012;39(12):10957-10970. doi:10.1007/s11033-012-1997-x
Lam KL, Ishitsuka Y, Cheng Y, et al. Mechanism of supported membrane disruption by antimicrobial peptide protegrin-1. J Phys Chem B. 2006;110(42):21282-21286. doi:10.1021/jp0630065
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Vladislava V. Khalenko, Kseniia V. Obedkova, Julian R. Ryzhov, Kseniia V. Storozheva, Galina Kh. Safarian, Alevtina M Savicheva, Olga V. Budilovskaya , Anna A. Krysanova, Aleksandr M. Gzgzyan, Olesya N. Bespalova, Natalya I. Tapilskaya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
